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Testing – Variant Annotation Tools: A Performance Evaluation Study
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EVALUATION

INTRODUCTION
With the completion of the draft sequence of the human genome in 2001 and
emergence of transformative technologies in all areas of genomics, the first two
decades of the 21st century have witnessed a dramatic transition from low
resolution, single locus, genetic testing to high resolution, genome wide testing in
medical practice.

The 296 variants were distributed with
respect to their classification (SNVs,
Deletions, Duplications, Complex, or
Insertions) to constitute the ground truth
set. Our investigation revealed that a
majority of the variants, 276 of the 296 or
93.2% were single nucleotide variants or
SNV’s, followed by deletions, duplications,
and complex and insertions.

Needle in a Haystack – Variant Identification and Annotation
While 4M variants/individual can be detected
with whole genome sequencing, exome
sequencing results in 20,000 variants. After
systematic filtering for rate and proteinchanging variants, a single exome harbors
anywhere from 100-200 potential disease
causing changes.

The 296 variants were independently
annotated using Alamut Batch and VEP,
and their annotation profiles were
found to be relatively concordant,
although VEP was unable to identify
one of the variants.
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When compared with the ground
truth set, 293 of the 296 variants
(98.9%) were concordant between
VEP, Alamut Batch and the ground
truth set. VEP correctly annotated
295 of the 296 variants.
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DISCORDANT VARIANTS BETWEEN VEP AND GROUND TRUTH

A battery of commercial and lab developed tools are available for variant
identification and most often multiple independent tools are incorporated in the
clinical pipeline. HGVS (Human Genome Variation Society) nomenclature is now a
de-facto clinical standard for reporting DNA sequence variants.

RESEARCH DESIGN
Robust identification and annotation of genetic variants relevant for human
germline disorders is foundational for clinical Next Generation Sequencing (NGS)
assays. Performance of two variant annotation software, Variant Effect Predictor
or VEP (Ensemble), and Alamut Batch (Interactive Biosoftware) was evaluated. A
test set of 296 intronic and exonic variants across 191 genes, previously classified
and reviewed in clinical reports by the Molecular Diagnostics Laboratory at Lurie
Children’s Hospital was curated and used. These variants were generated by
targeted gene panel sequencing using the ~4700 gene medical exome panel on
105 patients. The 296 variants were manually reviewed using Alamut Visual and
Integrated genome viewer (IGV), and orthogonally confirmed with Sanger
sequencing.
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Of the three discordant SNVs between VEP and Alamut Batch, Alamut Batch called
one variant in the CSF3R gene as exonic as illustrated by the c. nomenclature,
whereas both the Ground Truth and VEP were concordant in reporting it as
intronic. The implications of this difference in the region can potentially be severe
resulting in an incorrect diagnosis of patient’s condition.

CONCLUSIONS AND FUTURE DIRECTIONS
• With respect to HGVS nomenclature standards and clinical integrity, VEP
produced more accurate variant annotations (295/296) than Alamut Batch
(294/296). For discordant variants, these differences were due to usage of
transcript versions that differ in exon/intron configurations as reference by the
two algorithms, thereby producing discrepant results in annotated variants.
• Without accurate genetic variant identification and annotation, clinical
interpretation of Variants of Unknown Significance (VUS) will continue to be a
challenge for clinical diagnostics. Therefore, appropriate and validated methods
of variant annotation are critical in the post analytical phases of clinical testing,
and in ensuring that patients receive an accurate molecular diagnosis for their
genetic conditions.
• Annotation of other complex variants across these two software and others will
be assessed in our ongoing effort.

ACKNOWLEDGEMENTS

• Mr. Chris McCabe and Mr.
Nicholas Miller – Bioinformatics Group, Ann &
ACKNOWLEDGEMENTS
Robert
Lurie Children’s
Hospital
IL Group, Ann & Robert H. Lurie
• Mr.
ChrisH.
McCabe
and Mr. Nicholas
Millerof–Chicago,
Bioinformatics
Chicago,
IL
• Children’s
ScientificHospital
Inquiryofand
Research
Program – Illinois Mathematics and Science
• Scientific
Inquiry
Academy,
IL and Research Program – Illinois Mathematics and Science Academy, IL

